Does the media favor ONC or ELAN?

In the previous week, Elanco Animal Health had 1 more articles in the media than BeOne Medicines. MarketBeat recorded 9 mentions for Elanco Animal Health and 8 mentions for BeOne Medicines. Elanco Animal Health's average media sentiment score of 1.15 beat BeOne Medicines' score of -0.26 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elanco Animal Health 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ELAN or RVMD?

In the previous week, Elanco Animal Health had 4 more articles in the media than Revolution Medicines. MarketBeat recorded 9 mentions for Elanco Animal Health and 5 mentions for Revolution Medicines. Elanco Animal Health's average media sentiment score of 1.15 beat Revolution Medicines' score of 0.97 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer ELAN or BNTX?

In the previous week, Elanco Animal Health had 1 more articles in the media than BioNTech. MarketBeat recorded 9 mentions for Elanco Animal Health and 8 mentions for BioNTech. Elanco Animal Health's average media sentiment score of 1.15 beat BioNTech's score of 0.60 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioNTech 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to INSM or ELAN?

In the previous week, Insmed had 6 more articles in the media than Elanco Animal Health. MarketBeat recorded 15 mentions for Insmed and 9 mentions for Elanco Animal Health. Insmed's average media sentiment score of 1.58 beat Elanco Animal Health's score of 1.15 indicating that Insmed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insmed 13 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Elanco Animal Health 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Elanco Animal Health (ELAN) Competitors

$23.86 -0.12 (-0.50%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$23.88 +0.03 (+0.10%)

As of 05/29/2026 07:38 PM Eastern

Compare

ELAN vs. TEVA, ONC, RVMD, BNTX, and INSM

Should you buy Elanco Animal Health stock or one of its competitors? MarketBeat compares Elanco Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), BeOne Medicines (ONC), Revolution Medicines (RVMD), BioNTech (BNTX), and Insmed (INSM). These companies are all part of the "pharmaceutical products" industry.

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Elanco Animal Health (NYSE:ELAN) and Teva Pharmaceutical Industries (NYSE:TEVA) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

Elanco Animal Health presently has a consensus target price of $28.20, indicating a potential upside of 18.19%. Teva Pharmaceutical Industries has a consensus target price of $41.78, indicating a potential upside of 18.27%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, analysts clearly believe Teva Pharmaceutical Industries is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Teva Pharmaceutical Industries	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80

Elanco Animal Health has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market. Comparatively, Teva Pharmaceutical Industries has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by company insiders. Comparatively, 0.5% of Teva Pharmaceutical Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Teva Pharmaceutical Industries had 4 more articles in the media than Elanco Animal Health. MarketBeat recorded 13 mentions for Teva Pharmaceutical Industries and 9 mentions for Elanco Animal Health. Teva Pharmaceutical Industries' average media sentiment score of 1.48 beat Elanco Animal Health's score of 1.15 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teva Pharmaceutical Industries	11 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teva Pharmaceutical Industries has a net margin of 9.01% compared to Elanco Animal Health's net margin of -4.95%. Teva Pharmaceutical Industries' return on equity of 43.53% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
Teva Pharmaceutical Industries	9.01%	43.53%	8.19%

Teva Pharmaceutical Industries has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.53	-$232M	-$0.50	N/A
Teva Pharmaceutical Industries	$17.26B	2.35	$1.41B	$1.33	26.56

Summary

Teva Pharmaceutical Industries beats Elanco Animal Health on 11 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to BeOne Medicines?

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Elanco Animal Health had 1 more articles in the media than BeOne Medicines. MarketBeat recorded 9 mentions for Elanco Animal Health and 8 mentions for BeOne Medicines. Elanco Animal Health's average media sentiment score of 1.15 beat BeOne Medicines' score of -0.26 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elanco Animal Health	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BeOne Medicines currently has a consensus price target of $389.15, indicating a potential upside of 35.16%. Elanco Animal Health has a consensus price target of $28.20, indicating a potential upside of 18.19%. Given BeOne Medicines' stronger consensus rating and higher possible upside, equities analysts clearly believe BeOne Medicines is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.80
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 6.2% of BeOne Medicines shares are owned by company insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

BeOne Medicines has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

BeOne Medicines has a net margin of 8.94% compared to Elanco Animal Health's net margin of -4.95%. BeOne Medicines' return on equity of 12.06% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	8.94%	12.06%	6.69%
Elanco Animal Health	-4.95%	7.42%	3.66%

BeOne Medicines has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than BeOne Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$5.34B	5.91	$286.93M	$4.47	64.41
Elanco Animal Health	$4.72B	2.53	-$232M	-$0.50	N/A

Summary

BeOne Medicines beats Elanco Animal Health on 12 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to Revolution Medicines?

Elanco Animal Health (NYSE:ELAN) and Revolution Medicines (NASDAQ:RVMD) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by insiders. Comparatively, 7.6% of Revolution Medicines shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Elanco Animal Health presently has a consensus price target of $28.20, indicating a potential upside of 18.19%. Revolution Medicines has a consensus price target of $111.35, indicating a potential downside of 29.29%. Given Elanco Animal Health's higher probable upside, equities analysts clearly believe Elanco Animal Health is more favorable than Revolution Medicines.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Revolution Medicines	1 Sell rating(s)	1 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	3.00

Elanco Animal Health has higher revenue and earnings than Revolution Medicines. Elanco Animal Health is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.53	-$232M	-$0.50	N/A
Revolution Medicines	$11.58M	2,891.21	-$1.13B	-$7.07	N/A

Revolution Medicines has a net margin of 0.00% compared to Elanco Animal Health's net margin of -4.95%. Elanco Animal Health's return on equity of 7.42% beat Revolution Medicines' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
Revolution Medicines	N/A	-83.22%	-59.06%

Elanco Animal Health has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, Revolution Medicines has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

In the previous week, Elanco Animal Health had 4 more articles in the media than Revolution Medicines. MarketBeat recorded 9 mentions for Elanco Animal Health and 5 mentions for Revolution Medicines. Elanco Animal Health's average media sentiment score of 1.15 beat Revolution Medicines' score of 0.97 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Revolution Medicines	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Elanco Animal Health beats Revolution Medicines on 10 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to BioNTech?

Elanco Animal Health (NYSE:ELAN) and BioNTech (NASDAQ:BNTX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Elanco Animal Health currently has a consensus price target of $28.20, suggesting a potential upside of 18.19%. BioNTech has a consensus price target of $129.56, suggesting a potential upside of 35.03%. Given BioNTech's higher possible upside, analysts plainly believe BioNTech is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
BioNTech	1 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.74

In the previous week, Elanco Animal Health had 1 more articles in the media than BioNTech. MarketBeat recorded 9 mentions for Elanco Animal Health and 8 mentions for BioNTech. Elanco Animal Health's average media sentiment score of 1.15 beat BioNTech's score of 0.60 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioNTech	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by company insiders. Comparatively, 19.2% of BioNTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Elanco Animal Health has higher revenue and earnings than BioNTech. Elanco Animal Health is trading at a lower price-to-earnings ratio than BioNTech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.53	-$232M	-$0.50	N/A
BioNTech	$3.25B	7.47	-$1.29B	-$5.88	N/A

Elanco Animal Health has a beta of 1.69, suggesting that its stock price is 69% more volatile than the broader market. Comparatively, BioNTech has a beta of 1.33, suggesting that its stock price is 33% more volatile than the broader market.

Elanco Animal Health has a net margin of -4.95% compared to BioNTech's net margin of -44.39%. Elanco Animal Health's return on equity of 7.42% beat BioNTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-4.95%	7.42%	3.66%
BioNTech	-44.39%	-5.30%	-4.62%

Summary

Elanco Animal Health beats BioNTech on 11 of the 16 factors compared between the two stocks.

How does Elanco Animal Health compare to Insmed?

Insmed (NASDAQ:INSM) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

97.5% of Elanco Animal Health shares are owned by institutional investors. 2.1% of Insmed shares are owned by company insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Insmed had 6 more articles in the media than Elanco Animal Health. MarketBeat recorded 15 mentions for Insmed and 9 mentions for Elanco Animal Health. Insmed's average media sentiment score of 1.58 beat Elanco Animal Health's score of 1.15 indicating that Insmed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insmed	13 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Elanco Animal Health	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elanco Animal Health has higher revenue and earnings than Insmed. Elanco Animal Health is trading at a lower price-to-earnings ratio than Insmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insmed	$606.42M	38.21	-$1.28B	-$5.75	N/A
Elanco Animal Health	$4.72B	2.53	-$232M	-$0.50	N/A

Insmed currently has a consensus target price of $210.95, suggesting a potential upside of 97.32%. Elanco Animal Health has a consensus target price of $28.20, suggesting a potential upside of 18.19%. Given Insmed's stronger consensus rating and higher possible upside, research analysts clearly believe Insmed is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insmed	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

Elanco Animal Health has a net margin of -4.95% compared to Insmed's net margin of -144.44%. Elanco Animal Health's return on equity of 7.42% beat Insmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insmed	-144.44%	-130.11%	-51.57%
Elanco Animal Health	-4.95%	7.42%	3.66%

Insmed has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market.

Summary

Insmed and Elanco Animal Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELAN vs. The Competition

Export

Metric	Elanco Animal Health	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$11.91B	$5.58B	$6.58B	$23.19B
Dividend Yield	N/A	1.56%	2.68%	4.09%
P/E Ratio	-47.72	31.50	18.22	27.79
Price / Sales	2.53	25.38	561.77	24.75
Price / Cash	10.28	16.23	27.44	19.43
Price / Book	1.81	3.17	10.04	4.70
Net Income	-$232M	$218.81M	$3.56B	$1.07B
7 Day Performance	9.61%	0.04%	2.85%	1.14%
1 Month Performance	6.64%	1.78%	4.59%	1.26%
1 Year Performance	77.27%	13.57%	37.62%	28.06%

Elanco Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELAN Elanco Animal Health	4.0889 of 5 stars	$23.86 -0.5%	$28.20 +18.2%	+77.3%	$11.91B	$4.72B	N/A	9,400	Positive News
TEVA Teva Pharmaceutical Industries	4.7751 of 5 stars	$34.04 -0.1%	$41.78 +22.7%	+110.6%	$39.17B	$17.26B	25.59	33,950
ONC BeOne Medicines	4.2427 of 5 stars	$310.25 flat	$389.15 +25.4%	+17.0%	$34.04B	$5.34B	69.41	12,000
RVMD Revolution Medicines	2.3608 of 5 stars	$151.56 flat	$111.35 -26.5%	+293.9%	$32.22B	$11.58M	N/A	250
BNTX BioNTech	3.1711 of 5 stars	$92.14 flat	$128.44 +39.4%	+0.3%	$23.30B	$3.25B	N/A	7,807	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELAN) was last updated on 5/31/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elanco Animal Health (ELAN) Competitors

ELAN vs. TEVA, ONC, RVMD, BNTX, and INSM

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Summary

How does Elanco Animal Health compare to Revolution Medicines?

Summary

How does Elanco Animal Health compare to BioNTech?

Summary

How does Elanco Animal Health compare to Insmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elanco Animal Health (ELAN) Competitors

ELAN vs. TEVA, ONC, RVMD, BNTX, and INSM

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Do analysts prefer ELAN or TEVA?

Which has more volatility and risk, ELAN or TEVA?

Do insiders & institutionals believe in ELAN or TEVA?

Does the media prefer ELAN or TEVA?

Is ELAN or TEVA more profitable?

Which has better earnings & valuation, ELAN or TEVA?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Does the media favor ONC or ELAN?

Do analysts rate ONC or ELAN?

Do insiders and institutionals have more ownership in ONC or ELAN?

Which has more risk and volatility, ONC or ELAN?

Is ONC or ELAN more profitable?

Which has preferable valuation and earnings, ONC or ELAN?

Summary

How does Elanco Animal Health compare to Revolution Medicines?

Do institutionals and insiders believe in ELAN or RVMD?

Do analysts recommend ELAN or RVMD?

Which has preferable valuation & earnings, ELAN or RVMD?

Is ELAN or RVMD more profitable?

Which has more volatility & risk, ELAN or RVMD?

Does the media prefer ELAN or RVMD?

Summary

How does Elanco Animal Health compare to BioNTech?

Do analysts prefer ELAN or BNTX?

Does the media prefer ELAN or BNTX?

Do insiders & institutionals have more ownership in ELAN or BNTX?

Which has better valuation & earnings, ELAN or BNTX?

Which has more risk and volatility, ELAN or BNTX?

Is ELAN or BNTX more profitable?

Summary

How does Elanco Animal Health compare to Insmed?

Do insiders & institutionals hold more shares of INSM or ELAN?

Does the media refer more to INSM or ELAN?

Which has better valuation and earnings, INSM or ELAN?

Do analysts recommend INSM or ELAN?

Is INSM or ELAN more profitable?

Which has more risk & volatility, INSM or ELAN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools